Preformed IgG Antibodies Against Major Histocompatibility Complex Class II Antigens Are Major Risk Factors for High-grade Cellular Rejection in Recipients of Heart Transplantation
Authors:
- 25 August 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (8) , 786-793
Abstract
Background —Preformed anti-HLA antibodies reacting specifically with donor lymphocytes have been associated with acute vascular rejection and early cardiac allograft failure. However, the effect of preformed anti-HLA antibodies directed against allogeneic major histocompatibility complex (MHC) class I or II antigens of a donor panel on heart transplantation outcome has not been extensively studied. Methods and Results —The study group consisted of 68 patients who received cardiac transplants between 1989 and 1996 and who were at high risk for developing anti-HLA antibodies before transplantation. The effect of preformed antibodies against allogeneic MHC class I or class II antigens on the development of early high-grade cellular rejection and on cumulative annual rejection frequency was determined. Both patients with left ventricular assist devices and retransplantation candidates had a similar increase in the frequency of IgG anti-MHC class II antibodies (IgG anti-II) compared with control subjects ( P P =0.006) and higher cumulative annual rejection frequency ( P Conclusions —These results emphasize the importance of specifically screening heart transplantation candidates for the presence of IgG antibodies directed against MHC class II molecules and suggest that strategies aimed at their reduction may have an impact on the onset and frequency of high-grade cellular rejections after transplantation.Keywords
This publication has 13 references indexed in Scilit:
- Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.Journal of Clinical Investigation, 1998
- NEW STRATEGIES FOR EARLY DIAGNOSIS OF HEART ALLOGRAFT REJECTION1Transplantation, 1997
- Epitope spreadingCurrent Opinion in Immunology, 1996
- Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?The Journal of Thoracic and Cardiovascular Surgery, 1996
- Indirect recognition of donor HLA-DR peptides in organ allograft rejection.Journal of Clinical Investigation, 1996
- The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology, 1993
- OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR-SPECIFIC CROSSMATCH—PRELIMINARY RESULTS WITH PLASMAPHERESISTransplantation, 1992
- THE ROLE OF ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATIONTransplantation, 1991
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958